Phase 4 Osteoarthritis Trial, Recruiting NCT06084364 Sponsor: Diakonhjemmet Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Phase 4 Osteoarthritis Trial, Recruiting

NCT06084364
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 85 years old (male or female)
  • You have been diagnosed with osteoarthritis (a type of joint wear and tear) in the joint at the base of your thumb, confirmed by an X-ray or ultrasound
  • An ultrasound has shown inflammation in that thumb joint
  • You have pain of at least 3 out of 10 in that thumb joint, both at rest and during activity, measured at two separate appointments
  • The trial doctor has assessed you as suitable to receive the study medication (Kenacort-T, a steroid injection)

Who may not be able to join:

  • You have worn a thumb splint most days, or done structured hand exercises, in the last 12 weeks
  • You have had a steroid or other injection into that thumb joint in the last 12 weeks
  • You have had more than 3 previous steroid injections into that thumb joint
  • You have used steroid tablets, steroid injections into a muscle, or steroid drips in the last 12 weeks
  • You have had surgery on that thumb joint in the past
  • You are planning to have hand surgery in the next 24 weeks
  • You are unwilling to stop using anti-inflammatory painkillers (such as ibuprofen, diclofenac, naproxen, or etoricoxib) on your hands during the study
  • You have a condition that causes widespread joint inflammation (such as rheumatoid arthritis, psoriatic arthritis, or gout), or another condition that could better explain your hand pain (confirm with trial site)
  • You have been diagnosed with fibromyalgia (a condition causing widespread pain)
  • You have been diagnosed with psoriasis (a skin condition)
  • You have an infection, skin disease, or wound near the thumb joint where the injection would be given
  • You have serious other health conditions, memory or thinking problems, or issues with alcohol or substance use that might make it hard to follow the study rules
  • You have a severe or uncontrolled infection
  • You are known to be allergic to the study medication (Triamcinolone acetonide/Kenacort) or any of its ingredients
  • You are currently taking part in another clinical trial
  • You are taking a type of heart medication called digitalis glycosides
  • You have received a live vaccine in the last 2 weeks
  • You are not able to speak or understand Norwegian
  • You are currently pregnant or planning to become pregnant in the next 6 months
  • The trial doctor has any other concern that you may not be able to follow the study procedures (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Ida Kristin Haugen, MD, PhD, Diakonhjemmet Hospital

Phone: +4795859884

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Diakonhjemmet Hospital
Registry
ClinicalTrials.gov
Start date
3 November 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Pain during activities in thumb base joint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov